The effect of anti-IL-6 treatment in patients with ankylosing spondylitis has also been reported — studies revealed that the anti-IL-6 receptor antibody did not prevent the progression of spinal changes associated with ankylosis [14]. This evidence concerns the gene IL6 and ankylosis.